RXDX
First Trust Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-57,258
| Closed | -$6.14M | – | 2477 |
|
|
2023
Q1 | $6.14M | Sell |
57,258
-59,276
| -51% | -$6.36M | 0.01% | 1141 |
|
|
2022
Q4 | $12.8M | Buy |
116,534
+26,916
| +30% | +$2.96M | 0.02% | 889 |
|
|
2022
Q3 | $5.29M | Sell |
89,618
-34,351
| -28% | -$2.03M | 0.01% | 1164 |
|
|
2022
Q2 | $3.5M | Buy |
123,969
+93,952
| +313% | +$2.65M | ﹤0.01% | 1454 |
|
|
2022
Q1 | $1.13M | Buy |
+30,017
| New | +$1.13M | ﹤0.01% | 2006 |
|